Cargando…

Lopinavir/ritonavir in the treatment of HIV-1 infection: a review

Lopinavir/ritonavir is the first and only coformulated HIV-1 protease inhibitor (PI). Large clinical trials have demonstrated lopinavir/ritonavir’s clinical efficacy in both antiretroviral-naïve and -experienced patients. The immunologic and virologic benefits of treatment with this agent have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandwani, Ashish, Shuter, Jonathan
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621403/
https://www.ncbi.nlm.nih.gov/pubmed/19209283

Ejemplares similares